Form 4 for OBIO Orchestra BioMed Holdings, Inc.
Accepted 2023-01-26 00:00:00 ET · period of report 2023-01-24 · accession 0001062993-23-001419 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-01-26 | 2023-01-24 | OBIO | WONG RODERICK | CEO, Dir, 10% | P - Purchase | $10.00 | +1.81M | 2.81M | +181% | +$18.09M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2023-01-24 | P | A | 1,808,512 | $10.00 | 2,808,512 | I See footnote | — | — | (F1) Held by certain affiliated funds managed by RTW Investments, LP ("RTW"), and Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW. The reporting person disclaims beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of his pecuniary interest therein. |